Mechanisms of Extracellularly Regulated Kinases 1/2 Activation in Adrenal Glomerulosa Cells by Lysophosphatidic Acid and Epidermal Growth Factor
Open Access
- 1 October 2005
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 19 (10) , 2535-2548
- https://doi.org/10.1210/me.2005-0082
Abstract
The regulation of adrenal function, including aldosterone production from adrenal glomerulosa cells, is dependent on a variety of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). In many cell types, GPCR-mediated MAPK activation is mediated through transactivation of RTKs, in particular the epidermal growth factor (EGF) receptor (EGF-R). However, the extent to which this cross-communication between GPCRs and RTKs is operative in the adrenal glomerulosa has not been defined. Bovine adrenal glomerulosa cells express receptors for lysophosphatidic acid (LPA) and EGF. In cultured bovine adrenal glomerulosa cells, LPA, which is predominantly coupled to Gi and partially to Gq/protein kinase C α and ε, caused phosphorylation of Src (at Tyr416), proline-rich tyrosine kinase (Pyk2 at Tyr402), EGF-R, protein kinase B/Akt, extracellularly regulated signal kinases 1/2, and their dependent protein, p90 ribosomal S6 kinase. Overexpression of dominant negative mutants of Ras or EGF-R, and selective inhibition of EGF-R kinase with AG1478, significantly reduced LPA-induced ERK1/2 phosphorylation. However, this was not impaired by inhibition of matrix metalloproteinase (MMP) and heparin-binding EGF. LPA-induced ERK1/2 activation occurs predominantly through EGF-R transactivation by Gi/Src and partly through activation of protein kinase C, which acts downstream of EGF-R and Ras. In contrast, LPA-induced phosphorylation of Shc and ERK1/2 in clonal hepatocytes (C9 cells) was primarily mediated through MMP-dependent transactivation of the EGF-R. These observations in adrenal glomerulosa and hepatic cells demonstrate that LPA phosphorylates ERK1/2 through EGF-R transactivation in a MMP-dependent or -independent manner in individual target cells. This reflects the ability of GPCRs expressed in cell lines and neoplastic cells to utilize distinct signaling pathways that can elicit altered responses compared with those of native tissues.Keywords
This publication has 58 references indexed in Scilit:
- Aldosterone as a cardiovascular risk factorTrends in Endocrinology & Metabolism, 2005
- The ins and outs of lysophosphatidic acid signalingBioEssays, 2004
- G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survivalJournal of Cellular Biochemistry, 2004
- Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling PathwaysPhysiological Reviews, 2004
- Transactivation joins multiple tracks to the ERK/MAPK cascadeNature Reviews Molecular Cell Biology, 2003
- A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophyTrends in Pharmacological Sciences, 2003
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Aldosterone in Congestive Heart FailureNew England Journal of Medicine, 2001
- EGF-stimulated aldosterone secretion is mediated by tyrosine phosphorylation but not by phospholipase C in cultured porcine adrenal glomerulosa cellsJournal of Korean Medical Science, 1998
- Angiotensin II-Induced Aldosterone Synthesis Is Potentiated by Epidermal Growth Factor*Endocrinology, 1991